Iantrek Drive Time Podcast Transistor (https://transistor.fm) https://feeds.transistor.fm/iantrek-drive-time-podcast-7f3ecb82-f436-4eb4-902d-bccb92a10895 A monthly conversation featuring stories from leadership, customer perspectives, and practical insights that connect company-wide work to our daily mission. Each episode is designed to inform, inspire, and equip the team as we show how Iantrek solutions address unmet market needs and improve what matters most: patient outcomes. © 2026 Iantrek 31ac2a43-f6dd-5695-b701-83a9b860bbea yes en Fri, 31 Jul 2026 10:41:31 -0400 Fri, 31 Jul 2026 10:42:41 -0400 https://img.transistorcdn.com/yr1EcEwZl-c59j-VacpTgN8WDDWv9ArqQR5cQz4GHMY/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS84MzM4/Nzc5N2Q0M2NmNjAz/YmExNjU5NGRjZWY2/Y2E0Mi5qcGc.jpg Iantrek Drive Time Podcast episodic Iantrek A monthly conversation featuring stories from leadership, customer perspectives, and practical insights that connect company-wide work to our daily mission. Each episode is designed to inform, inspire, and equip the team as we show how Iantrek solutions address unmet market needs and improve what matters most: patient outcomes. A monthly conversation featuring stories from leadership, customer perspectives, and practical insights that connect company-wide work to our daily mission. Iantrek No No Finding the Fit: Drs. Sawhney and Dublin on Patient Selection, Surgical Confidence and the AlloFlo Learning Curve 2 2 Finding the Fit: Drs. Sawhney and Dublin on Patient Selection, Surgical Confidence and the AlloFlo Learning Curve full e5b1d4c1-23df-4a3f-af18-18d6fc9f0315 https://share.transistor.fm/s/e3082c22 In this episode of Drive Time from Iantrek, Sara McLenighan speaks with Dr. Gagan Sawhney and Dr. Allison Dublin about where AlloFlo™ Uveo fits within the glaucoma treatment pathway. They discuss the gap between traditional MIGS and bleb-forming procedures, how their confidence evolved through early cases, and why patient selection is critical to success. For the field team, this episode offers practical guidance on supporting surgeons through the learning curve, reinforcing appropriate patient profiles, and helping build confidence with a controlled, bio-interventional approach.


Show Notes

2:03 — Defining the treatment gap between MIGS and bleb-forming procedures

4:38 — How AlloFlo first emerged as a potential solution in their practices

8:37 — Early-case learnings around anesthesia, heme control, cleft creation, and visualization

13:57 — Identifying the ideal AlloFlo patient and helping surgeons start the right way


Credits
Host: Sara McLenighan, Vice President of Sales
Guest: Dr. Gagan Sawhney and Dr. Allison Dublin
Production: Schaefer Advertising Co.


For internal use only.

]]> In this episode of Drive Time from Iantrek, Sara McLenighan speaks with Dr. Gagan Sawhney and Dr. Allison Dublin about where AlloFlo™ Uveo fits within the glaucoma treatment pathway. They discuss the gap between traditional MIGS and bleb-forming procedures, how their confidence evolved through early cases, and why patient selection is critical to success. For the field team, this episode offers practical guidance on supporting surgeons through the learning curve, reinforcing appropriate patient profiles, and helping build confidence with a controlled, bio-interventional approach.


Show Notes

2:03 — Defining the treatment gap between MIGS and bleb-forming procedures

4:38 — How AlloFlo first emerged as a potential solution in their practices

8:37 — Early-case learnings around anesthesia, heme control, cleft creation, and visualization

13:57 — Identifying the ideal AlloFlo patient and helping surgeons start the right way


Credits
Host: Sara McLenighan, Vice President of Sales
Guest: Dr. Gagan Sawhney and Dr. Allison Dublin
Production: Schaefer Advertising Co.


For internal use only.

]]> Fri, 31 Jul 2026 10:41:27 -0400 Iantrek Iantrek 1466 In this episode of Drive Time from Iantrek, Sara McLenighan speaks with Dr. Gagan Sawhney and Dr. Allison Dublin about where AlloFlo™ Uveo fits within the glaucoma treatment pathway. They discuss the gap between traditional MIGS and bleb-forming procedures, how their confidence evolved through early cases, and why patient selection is critical to success. For the field team, this episode offers practical guidance on supporting surgeons through the learning curve, reinforcing appropriate patient profiles, and helping build confidence with a controlled, bio-interventional approach.


Show Notes

2:03 — Defining the treatment gap between MIGS and bleb-forming procedures

4:38 — How AlloFlo first emerged as a potential solution in their practices

8:37 — Early-case learnings around anesthesia, heme control, cleft creation, and visualization

13:57 — Identifying the ideal AlloFlo patient and helping surgeons start the right way


Credits
Host: Sara McLenighan, Vice President of Sales
Guest: Dr. Gagan Sawhney and Dr. Allison Dublin
Production: Schaefer Advertising Co.


For internal use only.

]]> No Meet Them Where They Are: Drs. Paul Singh and Christine Funke on AlloFlo Adoption, Patient Selection, and Surgeon Support 1 1 Meet Them Where They Are: Drs. Paul Singh and Christine Funke on AlloFlo Adoption, Patient Selection, and Surgeon Support full 2e3a11d1-eedd-43a1-8913-7a36ee40bad6 https://share.transistor.fm/s/4acd2ee1 In this episode of Drive Time from Iantrek, Carey Kelson speaks with Dr. Paul Singh and Dr. Christine Funke about AlloFlo™ Uveo adoption, patient selection, and working in the uveoscleral space. They discuss why the post-MIGS treatment gap matters, which data points resonate with peers, and how AlloFlo has changed their approach to glaucoma care. Their message to the field team is clear: meet each surgeon where they are, identify the barrier, and help them build confidence with the right support.


Show Notes
0:59 — Carey Kelson introduces Dr. Paul Singh and Dr. Christine Funke
1:39 — How both surgeons became involved with Iantrek and AlloFlo™ Uveo
6:29 — Addressing surgeon hesitation around the uveoscleral space
9:00 — CREST data, IOP reduction, medication reduction, and safety discussion
15:27 — Practical guidance for new users: patient selection, cleft creation, and surgeon support


Credits
Host: Carey Kelson, Vice President of Market Development
Guest: Dr. Paul Singh and Dr. Christine Funke
Production: Schaefer Advertising Co.


For internal use only.

]]> In this episode of Drive Time from Iantrek, Carey Kelson speaks with Dr. Paul Singh and Dr. Christine Funke about AlloFlo™ Uveo adoption, patient selection, and working in the uveoscleral space. They discuss why the post-MIGS treatment gap matters, which data points resonate with peers, and how AlloFlo has changed their approach to glaucoma care. Their message to the field team is clear: meet each surgeon where they are, identify the barrier, and help them build confidence with the right support.


Show Notes
0:59 — Carey Kelson introduces Dr. Paul Singh and Dr. Christine Funke
1:39 — How both surgeons became involved with Iantrek and AlloFlo™ Uveo
6:29 — Addressing surgeon hesitation around the uveoscleral space
9:00 — CREST data, IOP reduction, medication reduction, and safety discussion
15:27 — Practical guidance for new users: patient selection, cleft creation, and surgeon support


Credits
Host: Carey Kelson, Vice President of Market Development
Guest: Dr. Paul Singh and Dr. Christine Funke
Production: Schaefer Advertising Co.


For internal use only.

]]> Fri, 01 May 2026 12:29:00 -0400 Iantrek Iantrek 2223 In this episode of Drive Time from Iantrek, Carey Kelson speaks with Dr. Paul Singh and Dr. Christine Funke about AlloFlo™ Uveo adoption, patient selection, and working in the uveoscleral space. They discuss why the post-MIGS treatment gap matters, which data points resonate with peers, and how AlloFlo has changed their approach to glaucoma care. Their message to the field team is clear: meet each surgeon where they are, identify the barrier, and help them build confidence with the right support.


Show Notes
0:59 — Carey Kelson introduces Dr. Paul Singh and Dr. Christine Funke
1:39 — How both surgeons became involved with Iantrek and AlloFlo™ Uveo
6:29 — Addressing surgeon hesitation around the uveoscleral space
9:00 — CREST data, IOP reduction, medication reduction, and safety discussion
15:27 — Practical guidance for new users: patient selection, cleft creation, and surgeon support


Credits
Host: Carey Kelson, Vice President of Market Development
Guest: Dr. Paul Singh and Dr. Christine Funke
Production: Schaefer Advertising Co.


For internal use only.

]]> iantrek, alloflow, ophthalmic surgery, Aqeuous Pathway, opthomology, optometrist No